一心堂(002727.SZ):擬進行增資及股權受讓取得本草堂56%股權
格隆匯7月9日丨一心堂(002727.SZ)公佈,公司於2021年7月9日召開第五屆董事會第六次臨時會議,審議通過《關於同意全資子公司一心堂藥業(四川)有限公司對外投資的議案》,同意公司全資子公司一心堂藥業(四川)有限公司(“一心堂四川”)以自有資金對四川本草堂藥業有限公司(“本草堂”、“目標公司”)進行增資及股權受讓,其中:
1、以自有資金人民幣5500萬元對本草堂進行增資(其中:2500萬元為註冊資本,3000萬元計入資本公積),此次增資完成後,本草堂註冊資本由人民幣10000萬元增加至12500萬元,一心堂四川持有本草堂20%股權。
2、以自有資金人民幣9900萬元受讓本草堂36%股權,此次股權轉讓完畢,一心堂四川持有本草堂56%股權。
本草堂目前主要包含針對加盟藥店、其它連鎖藥店、單體藥店、醫院、診所、衞生院及其它下游商業公司進行藥品銷售業務。
為滿足公司戰略發展的需要,保障公司在川渝區域各項業務的順利開展,拓展公司在川渝區域的覆蓋範圍,保障公司未來的產業戰略順利實施,進一步增加公司整體實力和綜合競爭力,提升公司的產品統採能力和配送能力,加強公司在川渝地區的藥品銷售網絡建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.